---
company: Community Healthcare Trust Inc
ticker: CHCT
form: 8-K
filed: 2026-08-04
accession: 0001631569-26-000039
source: https://www.sec.gov/Archives/edgar/data/1631569/000163156926000039/
---

# Community Healthcare Trust (CHCT) earnings release, August 4, 2026

Community Healthcare Trust Inc (CHCT) · Form 8-K, Item 2.02 · Filed 2026-08-04 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1631569/000163156926000039/)

News Release

Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2026

FRANKLIN, Tenn., August 4, 2026 / PRNewswire / -- Community Healthcare Trust Incorporated (NYSE:

CHCT) (the "Company") today announced results for the three months ended June 30, 2026. The Company reported net income for the three months ended June 30, 2026 of approximately $2.4 million, or $0.06 per diluted common share. Funds from operations ("FFO") and adjusted funds from operations ("AFFO") for the three months ended June 30, 2026 totaled $0.48 and $0.56 per diluted common share, respectively.

Highlights include:

Strategic Plan Presentation

A new, strategic Investor Presentation is furnished as Exhibit 99.3 on our Form 8-K filed on August 4, 2026 and is also available on the Investor Relations section of the Company’s website at www.chct.reit. It highlights leadership's decisive steps to rightsize the dividend to fund growth. CHCT is enhancing its capital allocation policy to focus on acquisitions, redevelopment, occupancy growth, and operating improvements designed to drive long-term shareholder value. Key strategic priorities for the next 18-24 months include occupancy improvement to 92%, portfolio reinvestment with 9-12% yields on capital, strategic capital recycling with over $70 million of marketed dispositions, and acquisition growth beginning with the current $99 million high-quality pipeline under contract with 9-10% expected yields and approximately 2.5% escalators.

Dividend

The Board unanimously declared a quarterly common stock dividend of

$0.33 per share, payable on

August 31, 2026, to stockholders of record as of

August 19, 2026. This represents a 31% reduction from the prior dividend payment and lowers the Company's AFFO payout ratio to approximately

60%, enabling the dividend to grow with earnings going forward. Reallocating this capital is expected to provide an additional $25 million to $30 million of retained capital over the next two years to fund accretive acquisitions, portfolio reinvestments, and occupancy improvements.

Expanded Disclosure

The Company has revised and expanded its Supplemental Information, filed as Exhibit 99.2 to Form 8-K. The enhanced report introduces Funds Available for Distribution (FAD), detailing leasing commissions, tenant improvements, and recurring capital expenditures. Additional disclosures include year-to-date property investments, dispositions, and capital recycling activity, alongside detailed portfolio metrics such as asset/ownership structures, leasing activity, lease types, and rent escalators.

Items Impacting Our Results include:

• During the second quarter of 2026, the Company sold a property, received net proceeds of approximately $0.4 million, and recorded a $46,000 gain on sale.

• During the second quarter of 2026, the geriatric behavioral hospital operator, a tenant in six of the Company's properties, paid $0.4 million in rent, an increase of $0.1 million from the first quarter of 2026. In July 2025, the tenant signed a Letter of Intent (LOI) for the sale of its business to a behavioral healthcare provider. The buyer is finalizing legal and business due diligence and has entered the drafting phase of the definitive purchase documents, including new leases on the six hospitals owned by the Company. While the transaction is progressing, the Company cannot provide assurance regarding the specific timing or the ultimate certainty of the closing.¹

• The Company has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $99.0 million. The Company's expected returns on these investments are approximately 9.1% to 9.75%. The Company anticipates closing on one of these properties in the third quarter of 2026 and another in the fourth quarter of 2026 and the remaining two properties in 2027; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

• During the second quarter of 2026, the Company did not issue any shares under its ATM program.

About Community Healthcare Trust Incorporated

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of June 30, 2026, the Company had investments of approximately $1.2 billion in 197 real estate properties (including one property with sales-type leases). The properties are located in 36 states, totaling approximately 4.5 million square feet in the aggregate.

Additional information regarding the Company, including this quarter's operations, can be found at www.chct.reit. Please contact the Company at 615-771-3052 to request a printed copy of this information.

Cautionary Note Regarding Forward-Looking Statements... (truncated)to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the control of Community Healthcare Trust Incorporated (the "Company"). Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, prolonged government shutdown or budgetary reductions or impasses, tariffs and global trade tensions, and/or international conflicts (including the conflicts in the Ukraine and in the Middle East), and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this press release and undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.²

## Financial statements

### Income Statement (Statements Of Operations Items — (Amounts in thousands, except per share data))

| | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | 2Q 2025 |
|---|---:|---:|---:|---:|---:|
| Revenues | 31,224 | 31,524 | 30,946 | 31,086 | 29,085 |
| Net income (loss) | 2,364 | 2,548 | 14,428 | 1,640 | -12,557 |
| NOI | 25,359 | 25,155 | 24,932 | 25,156 | 23,500 |
| EBITDAre | 20,472 | 20,050 | 20,173 | 20,505 | 4,274 |
| Adjusted EBITDAre | 23,250 | 22,761 | 22,772 | 22,970 | 20,068 |
| FFO | 13,218 | 13,399 | 13,329 | 13,547 | 6,336 |
| AFFO | 15,405 | 15,350 | 14,943 | 15,099 | 13,585 |
| FAD | 12,994 | 13,313 | 11,578 | 11,863 | 11,289 |
| Per Diluted Share: | Net income (loss) attributable to common shareholders | 0.06 | 0.07 | 0.51 | 0.03 | -0.5 |
| Per Diluted Share: | FFO | 0.48 | 0.49 | 0.49 | 0.5 | 0.23 |
| Per Diluted Share: | AFFO | 0.56 | 0.56 | 0.55 | 0.56 | 0.5 |
| Per Diluted Share: | Balance Sheet Items | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | 2Q 2025 |
| Assets | Total real estate properties | 1,241,615 | 1,238,080 | 1,203,229 | 1,190,151 | 1,158,312 |
| Assets | Total assets | 1,003,595 | 1,010,093 | 990,757 | 987,261 | 966,292 |
| Capitalization | Net debt | 559,321 | 559,260 | 532,199 | 530,138 | 500,077 |
| Capitalization | Total capitalization | 1,275,156 | 1,271,561 | 1,241,902 | 1,229,442 | 1,200,858 |
| Capitalization | Net debt/total capitalization | 43.9% | 44.0% | 42.9% | 43.1% | 41.6% |
| Capitalization | Market valuation | 523,809 | 454,006 | 467,501 | 435,613 | 471,766 |
| Capitalization | Enterprise value | 1,080,457 | 1,010,649 | 996,360 | 962,368 | 966,980 |

### Income Statement ((Amounts in thousands, except per share data))

| | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | 2Q 2025 |
|---|---:|---:|---:|---:|---:|
| Revenues | Rental income | 30,971 | 31,269 | 30,679 | 30,814 | 30,128 |
| Revenues | Other operating interest | 253 | 255 | 267 | 272 | -1,043 |
| Revenues | Total Revenues | 31,224 | 31,524 | 30,946 | 31,086 | 29,085 |
| Expenses | Property operating | 5,865 | 6,369 | 6,014 | 5,930 | 5,585 |
| Expenses | General and administrative (1) | 4,890 | 5,108 | 4,778 | 4,658 | 10,559 |
| Expenses | Depreciation and amortization | 10,738 | 10,657 | 10,814 | 10,902 | 10,879 |
| Expenses | Total Expenses | 21,493 | 22,134 | 21,606 | 21,490 | 27,023 |
| Other (Expense) Income | Gain (loss), net of impairment, on the sale of real estate assets | 46 | -46 | 12,051 | -888 | 640 |
| Other (Expense) Income | Interest expense | -7,428 | -6,799 | -6,959 | -7,075 | -6,592 |
| Other (Expense) Income | Credit loss reserve |  |  |  |  | -8,672 |
| Other (Expense) Income | Deferred income tax benefit (expense) | 12 |  | -23 |  |  |
| Other (Expense) Income | Interest and other income, net | 3 | 3 | 19 | 7 | 5 |
| Other (Expense) Income | Total Other (Expense) Income | -7,367 | -6,842 | 5,088 | -7,956 | -14,619 |
| Other (Expense) Income | Net Income (Loss) | 2,364 | 2,548 | 14,428 | 1,640 | -12,557 |
| Other (Expense) Income | Net Income (Loss) Per Common Share - Basic & Diluted | 0.06 | 0.07 | 0.51 | 0.03 | -0.5 |
| Other (Expense) Income | Weighted Average Common Shares Outstanding | 27,016 | 26,991 | 26,953 | 26,934 | 26,803 |
| Other (Expense) Income | Dividends Declared, Per Common Share, In The Period | 0.48 | 0.4775 | 0.475 | 0.4725 | 0.47 |
| Non-cash vs. Cash: | Non-cash (stock-based compensation) | 56.8 | 53.1 | 54.4 | 52.9 | 54.3 |
| Non-cash vs. Cash: | Cash | 43.2 | 46.9 | 45.6 | 47.1 | 45.7 |
| As a % of Revenue: | Non-cash (stock-based compensation) | 8.9 | 8.6 | 8.4 | 8 | 8.7 |
| As a % of Revenue: | Cash | 6.8 | 7.6 | 7 | 7.1 | 7.3 |

### Income Statement (Net Operating Income (NOI) — (Amounts in thousands))

| | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | 2Q 2025 |
|---|---:|---:|---:|---:|---:|
| Net income (loss) | 2,364 | 2,548 | 14,428 | 1,640 | -12,557 |
| General and administrative | 4,890 | 5,108 | 4,778 | 4,658 | 4,657 |
| Accelerated amortization of deferred compensation |  |  |  |  | 4,591 |
| Severance and transition-related compensation |  |  |  |  | 1,311 |
| Depreciation and amortization | 10,738 | 10,657 | 10,814 | 10,902 | 10,879 |
| (Gain) loss, net of impairment, on the sale of real estate assets | -46 | 46 | -12,051 | 888 | -640 |
| Credit loss reserve |  |  |  |  | 8,672 |
| Interest expense | 7,428 | 6,799 | 6,959 | 7,075 | 6,592 |
| Deferred Income tax (benefit) expense | -12 |  | 23 |  |  |
| Interest and other income, net | -3 | -3 | -19 | -7 | -5 |
| NOI | 25,359 | 25,155 | 24,932 | 25,156 | 23,500 |
| Annualized NOI | 101,436 | 100,620 | 99,728 | 100,624 | 94,000 |
| EBITDAre And Adjusted EBITDAre | Net income (loss) | 2,364 | 2,548 | 14,428 | 1,640 | -12,557 |
| EBITDAre And Adjusted EBITDAre | Interest expense | 7,428 | 6,799 | 6,959 | 7,075 | 6,592 |
| EBITDAre And Adjusted EBITDAre | Depreciation and amortization | 10,738 | 10,657 | 10,814 | 10,902 | 10,879 |
| EBITDAre And Adjusted EBITDAre | Deferred Income tax (benefit) expense | -12 |  | 23 |  |  |
| EBITDAre And Adjusted EBITDAre | (Gain) loss, net of impairment, on the sale of real estate assets | -46 | 46 | -12,051 | 888 | -640 |
| EBITDAre And Adjusted EBITDAre | EBITDAre | 20,472 | 20,050 | 20,173 | 20,505 | 4,274 |
| EBITDAre And Adjusted EBITDAre | Non-cash stock-based compensation expense | 2,778 | 2,711 | 2,599 | 2,465 | 2,531 |
| EBITDAre And Adjusted EBITDAre | Accelerated amortization of stock-based compensation |  |  |  |  | 4,591 |
| EBITDAre And Adjusted EBITDAre | Credit loss reserve |  |  |  |  | 8,672 |
| EBITDAre And Adjusted EBITDAre | Adjusted EBITDAre | 23,250 | 22,761 | 22,772 | 22,970 | 20,068 |
| EBITDAre And Adjusted EBITDAre | Adjusted EBITDAre Annualized | 93,000 | 91,044 | 91,088 | 91,880 | 80,272 |

### Income Statement (Three Months Ended June 30, — (Unaudited; Dollars and shares in thousands, except per share amounts))

| | Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| REVENUES | Rental income | 30,971 | 30,128 | 62,240 | 59,858 |
| REVENUES | Other operating interest | 253 | -1,043 | 508 | -695 |
| REVENUES |  | 31,224 | 29,085 | 62,748 | 59,163 |
| EXPENSES | Property operating | 5,865 | 5,585 | 12,234 | 11,680 |
| EXPENSES | General and administrative(1) | 4,890 | 10,559 | 9,998 | 15,659 |

### Balance Sheet ((Amounts in thousands))

| | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | 2Q 2025 |
|---|---:|---:|---:|---:|---:|
| Land and land improvements | 163,506 | 162,587 | 154,673 | 154,272 | 152,887 |
| Buildings, improvements, and lease intangibles | 1,077,295 | 1,074,680 | 1,047,743 | 1,035,070 | 1,004,616 |
| Personal property | 814 | 813 | 813 | 809 | 809 |
| Total real estate properties | 1,241,615 | 1,238,080 | 1,203,229 | 1,190,151 | 1,158,312 |
| Less accumulated depreciation | -301,593 | -290,958 | -280,316 | -272,481 | -262,961 |
| Total real estate properties, net | 940,022 | 947,122 | 922,913 | 917,670 | 895,351 |
| Cash and cash equivalents | 2,673 | 2,617 | 3,340 | 3,383 | 4,863 |
| Assets held for sale, net |  |  | 5,265 | 6,205 | 5,465 |
| Other assets, net | 60,900 | 60,354 | 59,239 | 60,003 | 60,613 |
| Total assets | 1,003,595 | 1,010,093 | 990,757 | 987,261 | 966,292 |
| Liabilities And Stockholders' Equity | Debt, net | 559,321 | 559,260 | 532,199 | 530,138 | 500,077 |
| Liabilities And Stockholders' Equity | Accounts payable and accrued liabilities | 17,691 | 16,431 | 14,925 | 17,205 | 13,944 |
| Liabilities And Stockholders' Equity | Other liabilities, net | 12,341 | 13,059 | 14,246 | 13,095 | 14,451 |
| Liabilities And Stockholders' Equity | Total liabilities | 589,353 | 588,750 | 561,370 | 560,438 | 528,472 |
| Liabilities And Stockholders' Equity | Common stock | 287 | 286 | 285 | 285 | 284 |
| Liabilities And Stockholders' Equity | Additional paid-in capital | 722,454 | 719,819 | 717,450 | 714,890 | 712,498 |
| Liabilities And Stockholders' Equity | Cumulative net income | 95,689 | 93,325 | 90,777 | 76,349 | 74,709 |
| Liabilities And Stockholders' Equity | Accumulated other comprehensive gain | 9,047 | 7,395 | 6,691 | 7,568 | 9,121 |
| Liabilities And Stockholders' Equity | Cumulative dividends | -413,235 | -399,482 | -385,816 | -372,269 | -358,792 |
| Liabilities And Stockholders' Equity | Total stockholders’ equity | 414,242 | 421,343 | 429,387 | 426,823 | 437,820 |
| Liabilities And Stockholders' Equity | Total liabilities and stockholders' equity | 1,003,595 | 1,010,093 | 990,757 | 987,261 | 966,292 |

### Balance Sheet (June 30, 2026 — (Dollars and shares in thousands, except per share amounts))

| | June 30, 2026 – (Unaudited) | December 31, 2025 |
|---|---:|---:|
| Real estate properties: | Land and land improvements | 163,506 | 154,673 |
| Real estate properties: | Buildings, improvements, and lease intangibles | 1,077,295 | 1,047,743 |
| Real estate properties: | Personal property | 814 | 813 |
| Real estate properties: | Total real estate properties | 1,241,615 | 1,203,229 |
| Real estate properties: | Less accumulated depreciation | -301,593 | -280,316 |
| Real estate properties: | Total real estate properties, net | 940,022 | 922,913 |
| Real estate properties: | Cash and cash equivalents | 2,673 | 3,340 |
| Real estate properties: | Assets held for sale |  | 5,265 |
| Real estate properties: | Other assets, net | 60,900 | 59,239 |
| Real estate properties: | Total assets | 1,003,595 | 990,757 |
| Liabilities | Debt, net | 559,321 | 532,199 |
| Liabilities | Accounts payable and accrued liabilities | 17,691 | 14,925 |
| Liabilities | Other liabilities, net | 12,341 | 14,246 |
| Liabilities | Total liabilities | 589,353 | 561,370 |
| Stockholders' Equity | Common stock, $0.01 par value; 450,000 shares authorized; 28,655 and 28,471 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 287 | 285 |
| Stockholders' Equity | Additional paid-in capital | 722,454 | 717,450 |
| Stockholders' Equity | Cumulative net income | 95,689 | 90,777 |
| Stockholders' Equity | Accumulated other comprehensive gain | 9,047 | 6,691 |
| Stockholders' Equity | Cumulative dividends | -413,235 | -385,816 |
| Stockholders' Equity | Total stockholders’ equity | 414,242 | 429,387 |
| Stockholders' Equity | Total liabilities and stockholders' equity | 1,003,595 | 990,757 |
